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 We describe here the development and evaluation of a novel air-dried HRM assay to 
detect eight major ESBL and carbapenemase genes 
 The sensitivity and specificity of this novel air-dried HRM assay in comparison to the 
reference molecular test was 94.7%-98.5% and 98.5%-99.2%  
 The assay had a phenotypic agreement of 91.1% when predicting phenotypic 
resistance to cefotaxime and meropenem among Enterobacteriaceae isolates 
 Cross platform validation showed almost perfect reproducibility in 5 different q-PCR 
platforms  
 No loss of sensitivity was observed after 8-months storage at room (20.4°C ± 0.7), 
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Objectives: This study aimed to develop and evaluate a novel air-dried high-resolution melt 
(HRM) assay to detect eight major extended spectrum beta-Lactamase (ESBL) (blaSHV and 
blaCTXM groups 1 and 9) and carbapenemase (blaNDM, blaIMP, blaKPC, blaVIM and blaOXA-48-like) 
genes that cause antimicrobial resistance to cephalosporins and carbapenems. 
Methods: The assay was evaluated using 439 DNA samples extracted from bacterial isolates 
from Nepal, Malawi and UK and 390 clinical isolates from Nepal with known antimicrobial 
susceptibility results. Assay reproducibility was evaluated across five different q-PCR 
instruments (Rotor-Gene Q, QuantStudio
TM
 5, CFX96, LightCycler® 480 and MIC). Assay 
stability was also assessed upon the assay storage in the refrigerator (6.2°C±0.9), room 
temperature (20.4°C±0.7) and oven (29.7°C±1.4) at six time points for eight months. 
Results: The sensitivity and specificity for detecting the ESBL and carbapenemase genes in 
comparison to the reference gel-base PCR and sequencing was 94.7% (95%CI: 92.5%-
96.5%) and 99.2% (95%CI: 98.8%-99.5%), and 98.5% (95%CI: 97.0%-99.4%) and 98.5% 
(95%CI: 98.0%-98.9%) when compared to the original HRM wet PCR mix format. The 
overall agreement was 91.1% (95%CI: 90.0%-92.9%) when predicting phenotypic resistance 
to cefotaxime and meropenem among Enterobacteriaceae isolates. We observed almost 
perfect inter-machine reproducibility of the air-dried HRM assay and no loss of sensitivity 
occurred under all storage conditions and time points.  
Conclusions: We present here a ready-to-use air-dried HRM-PCR assay that offers an easy, 
thermostable, fast and accurate tool for the detection of ESBL and carbapenemase genes in 
DNA samples to improve AMR. 
Word count: 245/250 
Keywords: antimicrobial resistance, extended spectrum beta-lactamase, carbapenemase, high 
resolution melting, molecular diagnostics 





Antimicrobial resistance (AMR) is a major global cause of death and the development of new 
antibiotics is considered a public health priority [1]. An estimated 700,000 deaths are 
attributable to AMR globally each year, and this number is predicted to rise to 10 million by 
2050 [2]. Identification of AMR is typically by culture-based phenotypic antimicrobial 
susceptibility testing (AST) which requires incubation, from primary sample, for 48 to 96 
hours. As clinical management decisions are often taken rapidly, the lack of timeliness of 
AST leads to empirical treatment, which is often inappropriate [3,4]. First line or broad-
spectrum antibiotics are often used in large doses to ensure their efficacy on the suspected but 
unknown aetiological pathogens [5,6]. Empirical treatment facilitates the emergence of 
AMR, increases the duration of hospitalisation, damages the patient microbiota and increases 
the cost of therapy [7–9]. Rapid diagnosis of AMR can enable targeted usage of antibiotics, 
improved patient outcomes and antimicrobial stewardship [4,6,10,11]. 
The most common mechanism of drug resistance in Gram-negative bacteria is the production 
of -lactamases, including the extended-spectrum -lactamases (ESBLs) and carbapenemases 
[12], which provide resistance to the -lactam antibiotics. Polymerase Chain Reaction (PCR) 
based detection of ESBLs and carbapenemase genes provide a faster diagnosis of AMR than 
phenotypic methods, which might in turn generate more timely information for treatment 
decisions [13,14]. Whist molecular methods for the detection and characterisation of 
microbial resistance genes are becoming increasingly established, with good agreement with 
phenotypic methods, producing faster results [15–17], their use in clinical settings is 
hampered by the high degree of multiplexing needed due to the many genes involved in an 
AMR phenotype. Additionally, PCR requires a cold chain to maintain the integrity of 
reagents, equipment, and trained staff, which are often unavailable in low- and middle-
income countries (LMICs). One approach that could facilitate the implementation of PCR 
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assays in LMICs would be to provide the PCR primers, Taq enzyme and buffer components 
dry in the PCR vessels. This process eliminates the need for a cold chain and simplify 
preparation, as only the addition of nuclease-free water and the DNA template is needed 
resuspend the PCR reagents [18–20]. Typically, this process would be done by lyophilisation 
of the reagents. Lyophilisation, also called freeze-drying, is the process of the removal of 
water from a product by volatilization and desorption to increase the lifespan of a product. 
However, lyophilisation is costly and requires the addition of excipients, such as 
cryoprotectants and bulking agents [19,21]. There are commercially available ready to use 
thermostable PCR kits for the detection of AMR genes such as GeneXpert CarbaR (Cepheid, 
USA) and FilmArray Blood culture ID (BioFire, USA), however these are expensive and 
require proprietary equipment making them difficult to use routinely and difficult to 
implement in some low-resource settings [22]. 
We report here the development and validation of an air dried HRM-PCR mix to detect the 
most frequent ESBLs and carbapenemase enzymes based on a previously validated in-house 
AMR HRM-PCR assay [23]. 
METHODS 
Air-dried HRM assay optimisation  
We adapted an in-house 9-plex HRM PCR [23] into a dry format to detect three major ESBL 
genes (blaSHV and blaCTXM groups 1 and 9) and five carbapenemase genes (blaNDM, blaIMP, 
blaKPC, blaVIM and blaOXA-48-like). For the dry-out process, AmpDRY™ (Biofortuna, UK) was 
used, which is a PCR reaction mix that allows direct air drying of the whole reaction 
including primers and reporter molecules and removes the need for lyophilisation systems 
and reagents. The composition of each HRM reaction included a mixture of 1x EvaGreen® 
dye (Biotium, Canada), primers for detecting ESBL groups and carbapenemase genes, [23] 
the proprietary air-drying PCR buffer AmpDRY™ (Biofortuna, UK) and PCR grade water to 
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a final volume of 6.25l. The reaction mixture was added into each of the wells of a 96-well 
PCR plate (Starlab, Germany) and was dried in an oven-drier (ElextriQ, UK) at 35°C for 17 
hours. PCR was performed by adding 2.5l of bacterial DNA and 500 mM Betaine (Sigma 
Aldrich, UK) in PCR grade water to each PCR well containing the dried reagents for a final 
reaction volume of 12.5l. When plates were not compatible with the thermocycler used 
(Rotor-Gene-Q), PCR plates were briefly centrifugated before PCR amplification and the 
mixture was transferred to the appropriate reaction vessels (Rotor-Gene-Q strip tubes). The 
optimised PCR amplification protocol consisted of an initial incubation step at 80°C for 15 
minutes, followed by 30 cycles of denaturation for 10 seconds at 95°C, annealing for 60 
seconds at 66°C and elongation for 10 seconds at 72°C monitoring the fluorescence in the 
FAM/SYBR channel. HRM analysis was carried out over a temperature range of 75°C to 
95°C taking a reading in the HRM/SYBR channel every 0.1°C, with a 2 second stabilisation 
between each step. Peak calling was automated and indicated by a peak at the predictive 
melting temperature (Tm) of the target visualised as the negative first derivative of the 
melting curve in the Rotor-Gene Q software. The Rotor-Gene Q (Qiagen, UK) was used for 
all the experiments except where stated otherwise. Optimal conditions of the assay were 
achieved by titration of individual reaction components, optimisation of amplification 
conditions and drying time. The original primer mix and their concentrations were as 
previously described [23], except that blaTEM was removed as it is ubiquitous in Escherichia 
coli and the most common variants are narrow spectrum. 
Stored bacterial DNA and reference molecular tests 
A panel of 439 DNA samples from well documented multidrug resistant (MDR) bacterial 
isolates from Nepal (n=293), the UK (n=103) and Malawi (n=43) was used to optimise and 
evaluate the air-dried HRM assay.  
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Bacterial DNA from Nepal: this comprises isolates collected from 2012 to 2016 at Patan 
Hospital, Kathmandu, and includes strains of E. coli (n=112), Acinetobacter spp. (n=72), 
Klebsiella pneumoniae (n=54), Enterobacter spp. (n=32), Pseudomonas aeruginosa (n=20), 
Klebsiella oxytoca (n=4), Proteus spp. (n=1), Providencia retgerii (n=1), and Serratia 
rubidaea (n=1). Isolates were collected during routine diagnostic testing from clinical 
samples. 
Bacterial DNA from Malawi: isolates were collected between 1996 and 2012 at Queen 
Elizabeth Central Hospital during routine diagnostic testing and comprised E. coli (n=25) and 
K. pneumoniae (n=18). The collection of isolates was approved by the University of Malawi 
College of Medicine Research and Ethics Committee (COMREC), Blantyre, under study 
number P.08/14/1614. 
Bacterial DNA from the UK: isolates were collected between 2012 and 2017 from the UK 
National Health Service hospitals and included E. coli (n=40), K. pneumoniae (n=27), 
Klebsiella aerogenes (n=12), Enterobacter cloacae (n=10), Citrobacter freundii (n=4), P. 
aeruginosa (n=4), Morganella morganii (n=2), and K. oxytoca (n=1). 
Further details of all isolates in the sample collection are available in Supplementary 
Materials. 
DNA from the Nepal and Malawi isolates was extracted using the boilate [24] method and 
isolates from the UK were extracted using the DNeasy Blood and Tissue kit (Qiagen). The 
isolates sourced in the UK and Nepal were screened for ESBL and carbapenemase markers 
using reference gel-based PCR published protocols [13,14] and the air-dried HRM assay. The 
reference PCR reaction mix was performed using DreamTaq PCR reaction mix (Thermo 
Fisher, UK), 2.5l of DNA and nuclease free water to a final volume of 12.5l. PCR 
amplification was visualised with PicoGreen
TM
 (Life Technologies, USA) staining on a 1% 
TBE (Tris-borate-EDTA) gel with 1% to 2% of agarose depending on the fragment size to 
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resolve. This reference gel-based PCR was not performed with the Malawian isolates as next 
generation sequencing data was available from previous studies [8,23]. In addition, the 439 
isolates were screened using the in-house 9-plex HRM PCR assay originally developed in our 
laboratory [23] using the commercially available Type-it® HRM kit (Qiagen). 
Bacterial strains for phenotype prediction evaluation in Nepal 
A set of 390 Gram negative bacteria with known phenotypes were chosen based on their 
resistance profile from a collection of characterised clinical isolates banked at Patan Hospital 
in Nepal. Bacterial phenotypes were determined using the disk diffusion test following the 
Clinical & Laboratory Standards Institute (CLSI) guidelines. Banked isolates were selected 
based on their resistance to meropenem (37%) and cefotaxime (85%) and were resuscitated 
on MacConkey agar (Thermo Fisher Scientific, USA) and DNA extracted by a boiling lysis 
method as described elsewhere [24]. Intermediate phenotypic profiles were not selected for 
the study. To evaluate the agreement between the phenotype and HRM result (genotype), 
isolates positive for any (one or more) ESBL groups and carbapenemase genes were 
considered resistant to cefotaxime and isolates positive for any (one or more) carbapenemase 
genes were considered resistant to meropenem. 
 Isolates included strains of E. coli (n=72), K. pneumoniae (n=107), Acinetobacter spp. 
(n=73), Enterobacter (n=63), Salmonella Typhi (n=25), K. oxytoca (n=16), P. aeruginosa 
(n=13), Salmonella Paratyphi (n=7), M. morganii (n=3), C. freundii (n=2), Serratia spp. 
(n=3), Proteus spp. (n=2) and P. rettgeri (n=1). 
Limit of detection  
Limit of detection (LOD) of the air-dried assay was evaluated for the ESBL genes blaCTXM-1 
and blaSHV, one E. coli isolate positive for blaCTXM-1 (isolate 1), one K. pneumoniae positive 
for blaSHV (isolate 2), and one K. pneumoniae isolate harbouring for both genes blaCTXM-1 and 
blaSHV (isolate 3) to estimate the LOD in isolates coproducing multiple genes. The LOD was 
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performed following a published protocol [25]. Briefly, a single colony of each isolate was 
incubated at 37 °C for three hours in 5 ml of Luria-Bertani (LB) broth (ThermoFisher 
Scientific, UK), cultures were then sequentially diluted 1:10 in LB broth, and 10μl of each 
dilution was plated in triplicate on LB agar. The plates were then incubated overnight at 37 
°C and the colonies counted to quantify the CFU/ml in the suspension. Two aliquots of 200l 
of each of the suspensions were taken and processed following two extraction methodologies: 
DNeasy Blood and Tissue kit (Qiagen) and the boilate technique. DNA samples for each 
dilution series were tested in triplicate using the HRM assay. The LOD was defined as the 
lowest concentration at which the AMR genes were detected in all three replicates.  
Cross-platform validation  
To evaluate the compatibility of the air-dried HRM assay in a wide range of platforms, a set 
of 94 samples comprising all the resistance genes were tested using different qPCR systems 
including the Rotor-Gene Q, QuantStudio
TM
 5 (Thermofisher, USA), CFX96 (BioRad, USA), 
LightCycler® 480 (Roche Life Sciences, Germany) and MIC (Bio Molecular Systems, 
Australia). Amplification of the markers was assessed together with changes in Tms between 
platforms. 
Evaluation of the stability upon storage at different temperatures 
Stability of the dried-HRM assay was evaluated over time under different storage 
temperatures. A set of 89 samples comprising all the markers and isolates 1-3 at the dilution 
of the LOD and previous dilution were tested with plates stored at different conditions. One 
PCR plate with the dried reaction mix was stored for each of the following periods of time; 
one week (T1), two weeks (T2), one (T3), three (T4) and eight months (T5) and at fridge 
(5°C), room (20°C) and oven temperature (30°C). PCR plates were sealed with foil adhesive 
film and individually wrapped in heat sealed aluminium foil laminated pouches containing 
one desiccant sachet (Merck, USA). Temperature and humidity were recorded weekly. 




Statistical evaluations were performed with SPSS v.19 (2010, US). The outcome of all tests 
was labelled as 0 when negative or 1 when positive. The level of agreement between tests 
was determined using Cohen’s Kappa. Kappa coefficients () with values between 0 and 
0.20, 0.21 and 0.39, 0.40 and 0.59, 0.60 and 0.79, 0.80 and 0.90 and 91 to 1 were interpreted 
as no agreement, minimal, weak, moderate, strong, and almost perfect agreement, 
respectively. [26] Statistical significance of differences in Tms between platforms was 
measured using One-Way-ANOVA and differences of peak height between different storage 
conditions using One-Way-ANOVA with Tukey’s test for Post-Hoc analysis. Statistical 
significance was set at a p-value < 0.05. 
Results 
Air-dried HRM assay evaluation using banked DNA 
The air-dried HRM assay was capable of identifying the eight markers, each of which was 
characterised by the presence of a single peak at the expected Tm (Fig. 1a). The assay was 
also able to identify co-producers of up to four AMR markers (Fig. 1b). There was no overlap 
between adjacent peaks with a minimum separation of peak Tm of 0.8 °C allowing easy 
identification of multiple genes within the same sample.  
Measures of diagnostic accuracy and agreement of the air-dried HRM assay for detecting 
individual genes compared to the reference tests are detailed in Table 1 (PCR and WGS) and 
Table 2 (original 9-Plex HRM assay). The overall sensitivity and specificity of the air-dried 
HRM assay for all genetic markers in comparison with the reference gel-based PCR and 
sequencing were 94.7% (95%CI: 92.5%-96.5%) and 99.2% (95%CI: 98.8%-99.5%) and, in 
comparison with the original 9-plex HRM PCR assay [23] were 98.5% (95%CI: 97.0%-
99.4%) and 98.5% (95%CI: 98.0%-98.9%). When compared with the reference gel-based 
PCR and sequencing, the air-dried HRM assay had almost perfect agreement (=0.94-1) for 
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the ESBL blaCTXM group and carbapenemase markers and moderate agreement (=0.79) for 
blaSHV. blaSHV was often (77/102) found in coproducers of multiple genes and the sensitivity 
of blaSHV was lower in isolates carrying two (76.7%) and three genes (59.3%) than single 
producers of blaSHV (92.6%). The air-dried HRM assay was 100% sensitive and 99.3%-
99.7% for detecting carbapenemase co-producer isolates in comparison to the reference gel-
based/sequencing and original 9-plex HRM PCR assay respectively. 
Bacterial strains for phenotype prediction evaluation from Nepal 
The overall percentage of agreement of the air-dried HRM result and phenotype was 92.4% 
(95%CI: 89.9%-94.4%) for Enterobacteriaceae isolates and 57.1% (95%CI: 49.6%-64.4%) 
for non-Enterobacteriaceae isolates. The air-dried HRM assay had strong agreement with the 
phenotype (=0.845) among Enterobacteriaceae isolates with a sensitivity on predicting 
resistance to cefotaxime of 92.1% (88.0%-95.1%) and on predicting resistance to 
carbapenems 84.2% (75.3%-90.9%). However, the phenotype was poorly predicted among 
non-Enterobacteriaceae isolates using the air-dried HRM assay (Table 3). The sensitivity to 
meropenem was stratified by gene detected to investigate if the presence a particular 
carbapenemase gene was associated with false positivity as with the carriage of blaOXA-48-like 
genes does not always provide resistance to meropenem [27]. In this study the presence of 
blaOXA-48-like or any other carbapenemase gene was not associated with an increase of false 
positive rate in meropenem sensitive isolates (χ2 test p> 0.05). 
Cross-platform validation  
Almost perfect reproducibility was obtained on all instruments. Cut-off was established for 
each instrument by evaluating five threshold values set as 20%, 10%, 7.5%, 5% and 3% of 
the fluorescence of the highest peak. The optimal cut-off for the Rotor-Gene Q, QuantStudio 
and MIC was 5% of the fluoresce of the highest peak and for CFX96 and LightCycler® 480 
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it was 10%. These cut-offs produced almost perfect agreement with the reference tests 
(ĸ=0.935).  
The amplicon Tm (°C) shifted across platforms (Fig. 2) and ranged from±0.013°C to±0.99°C 
for blaCTXM-1,±0.07-1.09°C for blaCTXM-9,±0.08-1.15°C for blaIMP, ±0.02-1.26°C for blaKPC, 
±0.01-1.38°C for blaNDM, ±0.19-1.5°C for blaOXA-48-like, ±0.08-0.94°C for blaSHV and ±0.12-
1.27°C depending on the platform used. The Tm differences within the same peak and 
neighbouring peaks is shown in Tables 4a and 4b for each of the platforms. The Tm 
difference was not statistically significant for any of the platforms for either the type of peak, 
peaks within the same cluster (p=0.318) and neighbouring clusters (p=1.00). 
Limit of detection  
The limit of detection was 11.5, 102 and 960 cfu/reaction using DNeasy kit and 2.3, 20.4 and 
192 cfu/reaction by the boilate method for isolates carrying the blaCTXM-1, blaSHV and both 
blaCTXM-1 and blaSHV genes, respectively.  
Stability upon different storage conditions 
The effect of storage time and temperature on the air-dried HRM assay was assessed by 
analysing the plate mean fluorescence peak height and amplification of isolates, including at 
the LOD dilution. The average temperature for room storage, fridge and oven was 
20.4°C±0.7, 6.2°C±0.9 and 29.7°C±1.4 respectively, the humidity of the room was at 
36.5%±9.34. Overall, room temperature was the best storage condition compared to fridge 
and oven. The difference of mean fluoresce peak hight was not statistically significant within 
the same time point but was statistically significant between different time points (Fig. 3). 
The peak height started decreasing after storage time T3 for room and oven storage, and at T2 
for fridge storage (Fig. 3). Nonetheless, the difference of mean peak height produced with the 
air-dried HRM assay stored at time T3 (one month) was not statistically significant to the 
produced at T0, T1 and T2 at all storage conditions. The air-dried HRM assay recovered at 
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T4 and T5 (fridge only) produced significantly lower peak heights when compared to T1, T2 
and T3 (room temperature only). The mean peak height produced with the air-dried HRM 
assay stored at time T5 at room temperature, was comparable to all time points at all storage 
conditions and timepoints except at T1 for fridge storage (Fig. 3).  
Isolate 1 was negative at the LOD dilution at T3 under oven storage; isolate 2 was negative at 
the LOD dilution at T3 under room temperature and oven storage, and isolate 3 was positive 
in all runs tested (Fig 4). Of the 89 isolates tested, 100% were positive for all markers at all 
storage times and conditions, except for one sample that had one of three marker peaks below 
the cut-off (blaNDM) at T4 fridge storage (data not shown). 
Discussion 
In this study, we evaluated the performance of a dry format 8-plex HRM PCR assay to detect 
ESBL and carbapenemase genes. The assay showed high sensitivity, specificity and measures 
of agreement for all markers when compared to the reference tests. In addition, the drying 
process did not result in loss of performance, with all the resistance genes of the 89 clinical 
isolates correctly classified after 6 months of storage.  
The dry format of the assay overcomes key real-world challenges relating to transport, 
storage, and freezing/thawing issues, which can substantially lower the sensitivity of 
PCR.[28,29] This HRM assay presents several major advantages over fresh qPCR mixes as 
its resistant to long periods of storage at relatively warm temperatures (30 °C). Additionally, 
the HRM assay is more economic than fluorescent probes-based assays and has good 
performance using the boilate extraction methodThis would be of particular importance in 
LMICs where laboratories face insufficient and suboptimal cold chain capacity and scarcity 
of funds.[30]  
The air-dried HRM assay mix recovered at T4 and T5 stored in the fridge had lower peak 
heights that at oven and room temperature. This directs that fridge storage is the less suitable 
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for this assay than room temperature and oven. However, the detection of blaCTXM-1 and 
blaSHV was compromised at LOD dilution in isolate 1 and 2 at T3 for oven and room storage 
what suggests that detection of genes at very low concentrations can be compromised after 
one-month storage. 
The interpretation of results via analysis of the melting data can be automated in the systems’ 
software, which reduces subjectivity and intra-operator variation. The assay would be 
implementable in laboratories with access to qPCR facilities, but otherwise moderate 
resources, as all that is required is to reconstitute the mix and add template DNA. The level of 
multiplexing enables detection of the 8 major carbapenemase and ESBL gene families in a 
single tube with a sensitivity and specificity compared to reference molecular tests. 
Molecular detection of AMR genes can provide useful epidemiological data and enable the 
tracking of particular resistance genes at a hospital or national level.[31]  
Cross-platform validation illustrates a remarkably good performance on all 5 q-PCR systems 
(Rotor-Gene Q, QuantStudio
TM
 5, CFX96, LightCycler® 480 and MIC) evaluated, with 
minimal variation on the peak Tms. The cut-offs however required slight adjustment (5% or 
10% of the highest peak) to achieve the best performance, nevertheless this is straightforward 
correction that is automated for peak calling. 
The protocol has some constraints as a 24h incubation from primary sample to grow the 
isolates is still required prior DNA extraction. The assay has not been evaluated using direct 
clinical samples but the LOD obtained here indicates sensitivity to be insufficient to detect 
the low CFU/ml (>1/ml) possible in bacterial bloodstream infections. [32,33]. Since an 
internal amplification control has not been included to maximise sensitivity, the essay should 
be used with caution on samples that might contain PCR inhibitors such as stool or soil 
Another constraint of the air-dried HRM assay is the limitation to distinguish between 
narrow-spectrum and extended-spectrum resistance genes. This is particularly important for 
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blaSHV, however, as many blaSHV found in non-Klebsiella spp. are ESBL [34] all blaSHV were 
considered ESBL to maximise sensitivity of the test. This may over estimate resistance if is 
not interpretated with knowledge of the local epidemiology of the area. 
The overall agreement to predict bacterial phenotypes was strong amongst 
Enterobacteriaceae isolates but weak in non-Enterobacterial isolates. Thus, we do not 
recommend the use of the assay in non-Enterobacterial isolates. The high discrepancy among 
non-Enterobacteriaceae isolates can be explained as Acinetobacter spp. and Pseudomas spp. 
have other frequent mechanisms of resistance such as efflux pumps, permeability defects, 
modifications of target sites that are less common in the family Enterobacteriaceae [35,36], 
and chromosomal mediated AmpC enzymes[37] or blaGES-1[38]. An HRM assay for the 
detection of AmpC enzymes has already been developed[23] and could be easily adapted to a 
two tube AmpC and ESBL-Carb air-dried HRM assay using the methodology detailed here. 
Other reasons for phenotype-genotype mismatches include enzyme modifications that change 
the spectrum of activity and susceptibility profile [39], and also isolates with MICs close to 
the breakpoint being incorrectly classified during phenotypic susceptibility testing. [40]. 
To summarise, the air-dried HRM assay rapidly detected ESBL and carbapenemase genes 
high specificity and sensitivity and maintained performance after six months of storage at 
room temperatures. This 8-plex dry HRM assay was also successfully transferred to 5 
different PCR platforms indicating that can be reliably implemented in many laboratories. 
The assay can become a useful tool for AMR diagnosis and surveillance. 
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Figure 1. Melt curve profile of the air-dried HRM assay showing, 1a) the panel comprising 
the eight markers, being some of the isolates also co-producers and, 1b) detail of the 
simultaneous detection of two (pink), three (yellow) and four genes (blue) in isolates 
coproducers of ESBL and carbapenemases genes.  
1a) Orange: K. pneumoniae harbouring blaSHV and blaIMP genes; red: E. coli harbouring 
blaOXA-48-like and blaCTXM-9 genes; pink: K. pneumoniae harbouring blaSHV and blaKPC genes, 
blue: K. pneumoniae harbouring blaSHV and blaVIM genes; purple: Acinetobacter spp. 
harbouring blaNDM gene; and in grey: P. aeruginosa harbouring blaIMP gene.  
2b) Pink: K. pneumoniae harbouring blaSHV and blaCTXM-1 genes; yellow: K. pneumoniae 
harbouring blaOXA-48-like, blaSHV and blaCTXM-1 genes; and blue: K. pneumoniae harbouring 








Figure 2. Melting temperatures of the eight amplicons of the air-dried HRM assay ran in the 
CFX96, QuantStudio
TM
 5 (QStudio), Rotor-Gene-Q (RotorGene-Q), LightCycler® 480 
(LC48) and MIC. The whiskers show the maximum and minimum values, with the 
exceptions of outliers (circles) and extremes (rhombus). 
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Figure 3. Plate mean fluoresce peak height at the beginning of study (T0), one week (T1), 
two weeks (T2), one month (T3), three months (T4) and eight months (T5) under fridge 
storage (6.2°C±0.9), room temperature (20.4°C±0.7) and oven (29.7°C±1.4). Colour of 
asterisks indicates which storage conditions were statistically different between time points: 

















Figure 4. Peak height of the isolates 1 (blaCTXM-1 positive), 2 (blaSHV positive) and 3 
(blaCTXM-1 and blaSHV positive) at LOD dilution at different timepoints and storage conditions. 
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Table 1. Sensitivity (S), specificity (SP), accuracy (ACC) and agreement (ĸ) of the air-dried 
























 Reference PCR/WGS     












Positives 242 10 0.94 
Negatives 2 185  








Positives 14 1 0.96 
Negatives 0 422  








Positives 94 8 0.79 
Negatives 24 314  








Positives 112 3 0.98 
Negatives 1 321  








Positives 2 0 1.00 
Negatives 0 438  








Positives 8 0 1.00 
Negatives 0 432  








Positives 13 0 0.96 
Negatives 1 426  








Positives 17 2 0.94 
Negatives 0 421  
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Table 2. Sensitivity (S), specificity (SP), accuracy (ACC) and agreement (ĸ) of the air-dried 
HRM for detecting individual genes compared to the original 9- Plex HRM assay [23] using 










 9-Plex HRM     
 Positives Negatives S (95% CI) SP (95% CI) ACC (95% CI) ĸ 








Positives 237 13 0.93 
Negatives 2 185  








Positives 14 1 0.96 
Negatives 0 422  












Table 3. Sensitivity (S), specificity (SP), accuracy (ACC) and agreement (ĸ) of the air-dried 





































Positives 83 16 0.88 
Negatives 2 336  








Positives 106 8 0.93 
Negatives 3 322  








Positives 1 1 0.67 
Negatives 0 436  








Positives 8 0 1.00 
Negatives 0 429  








Positives 12 1 0.96 
Negatives 0 424  








Positives 13 5 0.85 
Negatives 0 421  











Table 4. Variability of melting temperature within the same and between neighbouring 
cluster obtained in the validated platforms.  
 
 


















 Meropenem     
HRM Carb Resistant Susceptible S (95% CI) SP (95% CI) ACC (95% CI) ĸ 







Negatives 15 200 
 Cefotaxime     
HRM Carb/ESBL Resistant Susceptible S (95% CI) SP (95% CI) ACC (95% CI) ĸ 







Negatives 20 44 
 
Non-Enterobacteriaceae 
 Meropenem     
HRM Carb Resistant Susceptible S (95% CI) SP (95% CI) ACC (95% CI) ĸ 







Negatives 27 36 
 Cefotaxime     
HRM Carb/ESBL Resistant Susceptible S (95% CI) SP (95% CI) ACC (95% CI) ĸ 







Negatives 42 3 
 Standard deviation of the melting temperatures within the same cluster (±°C) 
 CFX96 LightCycler® 480 MIC QuantStudioTM 5 Rotor-Gene Q 
BlaCTXM-1 0.27 0.19 0.15 0.25 0.08 
BlaCTXM-9 0.09 0.25 0.28 0.11 0.08 
BlaNDM 0.33 0.20 0.31 0.15 0.14 
BlaSHV 0.08 0.14 0.03 0.17 0.03 
BlaKPC 0.26 0.19 0.07 0.16 0.20 
BlaOXA-48-like 0.06 0.18 0.02 0.10 0.18 
BlaVIM 0.27 0.19 0.15 0.25 0.08 














 Mean difference of the melting temperatures within neighbouring clusters (°C) 
 CFX96 LightCycler® 480 MIC QuantStudioTM 5 Rotor-Gene Q 
BlaOXA-48-like & blaIMP 0.83 0.95 1.18 0.84 1.12 
BlaKPC & blaOXA-48-like 1.74 1.62 1.51 1.62 1.78 
BlaVIM & blaKPC 1.78 1.80 1.79 1.86 1.29 
BlaNDM & blaVIM 1.95 2.00 2.05 2.14 2.48 
BlaCTXM-1 & blaNDM 1.91 1.61 1.52 1.66 1.60 
BlaSHV & blaCTXM-1 1.20 1.15 1.14 1.16 1.27 
BlaCTXM-9 & blaSHV 0.96 1.02 1.11 1.01 0.88 
         
